Results 211 to 220 of about 75,548 (336)

Cell‐Free and Concentrated Ascites Reinfusion Therapy (CART) Shows Enhanced Efficacy in Gynecological Cancer Patients: A Post‐Marketing Surveillance Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Ascites management is crucial for gynecological cancer patients requiring long‐term treatment. Cancer type‐specific differences may influence CART outcomes, but comparative data remain limited. This study evaluated CART efficacy in gynecological versus other cancers.
Nami Tamura, Takashi Hirayama, Emiko Yoshida, Junna Terao, Misato Kawata, Kengo Hiranuma, Toshiyuki Okumura, Kazunari Fujino, Naoko Torii, Noriko Soneda, Go Murayama, Makio Kusaoi, Ken Yamaji, Yasuhisa Terao   +13 more
wiley   +1 more source

False detection and the value of combined tracer mapping in endometrial cancer: a dual case presentation. [PDF]

J Surg Case Rep
Szatkowski W, Pniewska K, Blecharz P.
europepmc   +1 more source

Development and Real‐World Evaluation of a Statewide Mainstream Model of Germline Genetic Testing for BRCA1/2 and Mismatch Repair Gene Variants (Lynch Syndrome)

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This translational quality improvement study evaluated a statewide pathway for mainstream genetic testing in South Australia. Adoption of mainstream BRCA1/2 testing increased significantly, but not MMR testing. Findings highlight the need for tailored, context‐specific strategies to integrate genetic testing into routine care across diverse cancer ...
Cally A. Jennings, Kathryn Cornthwaite, Michael Osborn, Ganessan Kichenadasse, Eryn Dow   +4 more
wiley   +1 more source

Lymphoepithelioma-like carcinoma with carcinosarcoma of the endometrium: a case report and literature review. [PDF]

Front Immunol
Xu J, Huang B, Zhu Y, Shi J, Zhou Q.
europepmc   +1 more source

The Demographics and Outcomes of Women With Stage II Endometrial Cancer Diagnosed in Australia 2005–2007

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Stage II endometrial cancer comprises 5% to 10% of cases and is pathologically diverse. Retrospective data guides recommendations which suggest surgical staging with adjuvant therapy, but the role of radical surgery and lymphadenectomy is uncertain, due to conflicting outcomes.
Jonathan Sandeford, Pearl Tong, Selvan Pather   +2 more
wiley   +1 more source

The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma. [PDF]

BMC Med Imaging
Liu M, Zheng X, Mo N, Liu Y, Jin E, Liang Y.   +5 more
europepmc   +1 more source

Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours

Andrology, EarlyView.
Abstract Background Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and ...
Sarah C. Moody, Daniela Fietz, Benedict Nathaniel, Mark Frydenberg, Ben Tran, Hans‐Christian Schuppe, Kate L. Loveland   +6 more
wiley   +1 more source

Disparities in End-of-Life Outcomes: A Demographic and Geographic Analysis of Endometrial Cancer Deaths in the United States. [PDF]

Cureus
Surapaneni SS, Narayan GN, Kapsikar SG, Gawadkar RJ, Rajkotwala SU, Ingle A, Kazi SM, Thakre AA, Awale MR, Saini M.   +9 more
europepmc   +1 more source

Systematic Sonographic Classification of Uterine Fibroids to Support Nonspecialist Infertility Investigation

Sonography, EarlyView.
Jennifer Alphonse, Michelle Fenech
wiley   +1 more source

Contemporary Surgical Management of Colorectal Cancer in Lynch Syndrome: Considering the Implications of Known Genotype

ANZ Journal of Surgery, EarlyView.
Contemporary surgical management of colorectal cancer in lynch syndrome: considering the implications of known genotype. ABSTRACT Background Lynch syndrome (LS) is an autosomal dominant disorder caused by germline mutations in mismatch repair (MMR) genes, accounting for 1%–3% of all colorectal cancer (CRC) diagnoses.
Ashley Jenkin, Kim‐Chi Phan‐Thien
wiley   +1 more source